BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Augustin Y, Staines HM, Krishna S. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing. Pharmacol Ther 2020;216:107706. [PMID: 33075360 DOI: 10.1016/j.pharmthera.2020.107706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nandi D, Cheema PS, Singal A, Bharti H, Nag A. Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1. Front Oncol 2021;11:751271. [PMID: 34900697 DOI: 10.3389/fonc.2021.751271] [Reference Citation Analysis]
2 Xie P, Jin Q, Li Y, Zhang J, Kang X, Zhu J, Mao X, Cao P, Liu C. Nanoparticle delivery of a triple-action Pt(IV) prodrug to overcome cisplatin resistance via synergistic effect. Biomater Sci 2021;10:153-7. [PMID: 34811566 DOI: 10.1039/d1bm01556g] [Reference Citation Analysis]
3 Na-Bangchang K, Plengsuriyakarn T, Karbwang J. The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review. Planta Med 2022. [PMID: 35468650 DOI: 10.1055/a-1676-9678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Moore CM, Wang J, Lin Q, Ferreira P, Avery MA, Elokely K, Staines HM, Krishna S. Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast. Antimicrob Agents Chemother 2022;:e0207921. [PMID: 35465707 DOI: 10.1128/aac.02079-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ma Z, Woon CY, Liu CG, Cheng JT, You M, Sethi G, Wong AL, Ho PC, Zhang D, Ong P, Wang L, Goh BC. Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge? Front Pharmacol 2021;12:828856. [PMID: 35035355 DOI: 10.3389/fphar.2021.828856] [Reference Citation Analysis]
6 Zhu J, Xiong Y, Zhang Y, Wen J, Cai N, Cheng K, Liang H, Zhang W. The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors. Oxid Med Cell Longev 2020;2020:8810785. [PMID: 33425217 DOI: 10.1155/2020/8810785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhi Y, Gao L, Wang B, Ren W, Liang KX, Zhi K. Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs. Front Cell Dev Biol 2021;9:686906. [PMID: 34235152 DOI: 10.3389/fcell.2021.686906] [Reference Citation Analysis]
8 Gao YY, Tian W, Zhang HN, Sun Y, Meng JR, Cao W, Li XQ. Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials. Arch Pharm Res 2021;44:354-77. [PMID: 33763843 DOI: 10.1007/s12272-021-01319-5] [Reference Citation Analysis]
9 Zhang S, Yi C, Li WW, Luo Y, Wu YZ, Ling HB. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers. Arch Pharm (Weinheim) 2022;:e2200086. [PMID: 35484335 DOI: 10.1002/ardp.202200086] [Reference Citation Analysis]
10 Li S, Peng T, Zhao X, Silva M, Liu L, Zhou W, Chen L, Zheng W. Artemether confers neuroprotection on cerebral ischemic injury through stimulation of the Erk1/2-P90rsk-CREB signaling pathway. Redox Biol 2021;46:102069. [PMID: 34303216 DOI: 10.1016/j.redox.2021.102069] [Reference Citation Analysis]
11 Patel OPS, Beteck RM, Legoabe LJ. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research. Eur J Med Chem 2021;213:113193. [PMID: 33508479 DOI: 10.1016/j.ejmech.2021.113193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Anwar S, Dasgupta D, Azum N, Alfaifi SY, Asiri AM, Alhumaydhi FA, Alsagaby SA, Sharaf SE, Shahwan M, Hassan MI. Inhibition of PDK3 by artemisinin, a repurposed antimalarial drug in cancer therapy. Journal of Molecular Liquids 2022;355:118928. [DOI: 10.1016/j.molliq.2022.118928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Turabi KS, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J. Drug repurposing-an emerging strategy in cancer therapeutics. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35695911 DOI: 10.1007/s00210-022-02263-x] [Reference Citation Analysis]